• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Jeff Sternstein

Gender
Male

Trophies

  1. 1

    First Message

    Post a message somewhere on the site to receive this.